Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
39S ribosomal protein L4, mitochondrial (MRPL4) is a nuclear-encoded protein that forms part of the large subunit (39S) of the mitochondrial ribosome, which is responsible for protein synthesis within mitochondria. MRPL4, like other mitochondrial ribosomal proteins, differs substantially in sequence across species, making homology-based identification difficult. Mammalian mitoribosomes, composed of about 75% protein to rRNA, play a central role in synthesizing proteins critical for oxidative phosphorylation and cellular energy supply. MRPL4 has also been shown in animal models to regulate Notch signaling independently of its role in translation, affecting developmental processes. There is currently no evidence that MRPL4 is a direct therapeutic target, nor are there drugs or safety concerns associated with the protein in humans.
None established for drugs (no direct pharmacological targeting documented)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 39S ribosomal protein L4, mitochondrial (MRPL4).